Alinidine (ST567) is a negative chronotrope that was developed in the 1970s and 1980s. It causes bradycardia by inhibiting the pacemaker current by altering the maximal channel conductance and alter the voltage threshold. The development of alinidine was halted because it was not sufficiently specific for its target. It also has a blocking effect on calcium channels and potassium channels. It also causes elongation of re-polarisation after an action potential.

CAS：33178-86-8
中文别名：烯苯胺咪;
英文别名：Alinidina [INN-Spanish];ST-567;Alinidin;2-[N-(2,6-dichloro-phenyl)-N-allyl-amino]-2-imidazoline;2-IMIDAZOLINE,2-(N-ALLYL-2,6-DICHLOROANILINO);Alinidinum [INN-Latin];2-(N-Allyl-N-(2,6-dichlorophenyl)amino)-2-imidazoline;Alinidine;allyl-(2,6-dichloro-phenyl)-(4,5-dihydro-1H-imidazol-2-yl)-amine;
分子式：C12H13Cl2N3
分子量：270.158
精确质量：269.049
Psa：27.63
Logp：2.7094

UNII：E7IDJ8DS1D

密度：1.3g/cm3
沸点：360.2ºC at 760mmHg
闪点：171.7ºC
折射率：1.611